Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Seres Therapeutics Inc. (MCRB)

28.4   0.09 (0.32%) 10-01 09:30
Open: 28.98 Pre. Close: 28.31
High: 28.4 Low: 28.29
Volume: 8,765 Market Cap: 2,536M
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. The company is headquartered in Cambridge, Massachusetts and currently employs 145 full-time employees. The firm is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The firm's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The firm is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is its lead product candidate, which is designed to prevent further recurrences of Clostridium difficile infection (CDI). The firm is developing additional product candidates, including SER-262 to prevent an initial recurrence of primary CDI; SER-287 and SER-301, to treat inflammatory bowel disease (IBD), including ulcerative colitis, and SER-155 to treat enteric bacterial pathogens.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 29.504 - 29.623 29.623 - 29.746
Low: 26.232 - 26.345 26.345 - 26.462
Close: 28.372 - 28.582 28.582 - 28.798

Technical analysis

as of: 2020-09-30 4:43:57 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 34.41     One year: 40.19
Support: Support1: 24.87    Support2: 22.03
Resistance: Resistance1: 29.46    Resistance2: 34.41
Pivot: 26.31
Moving Average: MA(5): 26.49     MA(20): 25.89
MA(100): 12.18     MA(250): 7.00
MACD: MACD(12,26): 1.77     Signal(9): 2.10
Stochastic oscillator: %K(14,3): 74.98     %D(3): 65.78
RSI: RSI(14): 67.94
52-week: High: 33.00  Low: 2.52  Change(%): 700.3
Average Vol(K): 3-Month: 311171  10-Days: 73994

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MCRB has closed above the upper band by 5.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 39.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB) gained 17.4% in a month. - Marketing Sentinel

Wed, 30 Sep 2020
Seres Therapeutics Inc. (MCRB) went up 7.28% yesterday: Is this the Most Sought-After Stock Today? - News Daemon

Wed, 30 Sep 2020
Highlights from the Ratings and Financial Report for Seres Therapeutics Inc. (MCRB) - The News Heater

Tue, 29 Sep 2020
Seres Therapeutics Inc. (MCRB) Soars 7.28% on September 29 - equities.com

Tue, 29 Sep 2020
Is Seres Therapeutics Inc (MCRB) Stock a Great Value? - InvestorsObserver

Tue, 29 Sep 2020
Zacks: Brokerages Expect Seres Therapeutics Inc (NASDAQ:MCRB) Will Post Quarterly Sales of $9.15 Million - MarketBeat

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 89
Shares Float (M) 51
% Held by Insiders 10.00
% Held by Institutions 80.15
Shares Short (K) 5,240
Shares Short P. Month (K) 8,920

Stock Financials

EPS -1.070
EPS Est This Year -2.510
EPS Est Next Year -2.860
Book Value (p.s.) -0.870
Profit Margin -262.34
Operating Margin -265.21
Return on Assets (ttm) -38.8
Return on Equity (ttm)
Qtrly Rev. Growth -51.8
Gross Profit (p.s.) -0.511
Sales Per Share 0.324
EBITDA (p.s.) -0.778
Qtrly Earnings Growth
Operating Cash Flow (M) -82
Levered Free Cash Flow (M) -36

Stock Valuations

PE Ratio -26.70
PEG Ratio
Price to Book value -32.84
Price to Sales 88.30
Price to Cash Flow -31.05

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.